Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors — Stella

Recruiting

Back to Colorectal Cancer Prevention trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Key details

Phase

Early testing

Sponsor

Massachusetts General Hospital

Collaborators

National Cancer Institute (NCI), Cancer Research UK

Enrollment target

~20 participants

Started

February 2026

Primary completion

March 2027

Age range

18 Years – 50 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov